Executive Summary of the NIAID Expert Panel Review on Medical Chemical Defense Research, March 19, 2003
Last Reviewed: March 19, 2003
Sample Application (K08): Al-Adra
Last Reviewed: September 13, 2024
Last Reviewed: September 26, 2023
Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020
Last Reviewed: March 8, 2022
Contractor Requirements for Clinical Trials
Last Reviewed: November 20, 2023
Sample Application (R44): Yingru Liu
Last Reviewed: November 25, 2022
Last Reviewed: August 28, 2012
Sample Summary Statement (K23): Friedman-Klabanoff
Last Reviewed: April 19, 2024
Harty Application
Last Reviewed: March 28, 2024
Foreign Organization System (FOS) Review (PDF)
Last Reviewed: November 26, 2019
DAIT Policy - Pharmacy Guidelines & Instructions for DAIT-Sponsored Clinical Trials & Networks
Last Reviewed: July 9, 2019
DMID Policy - SOP: Peripheral Blood Mononuclear Cells (PBMC) and Plasma Collection for Cell Activation/ Cell Mediated Immunity (CMI)
Last Reviewed: October 19, 2021
Sample Application (K01) Peter Rebeiro
Last Reviewed: November 29, 2022
NIH Consolidated Opening Statement Senate LHHS FY 2019 Hearing
Last Reviewed: August 16, 2018
Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002
Last Reviewed: December 31, 2002
Immunology Interest Group (IIG) Newsletter September 2023
Last Reviewed: October 10, 2023
The Jordan Report: Accelerated Development of Vaccines 2007
Last Reviewed: August 6, 2019
DAIT Interventional (Clinical Trials) Protocol Template
Last Reviewed: March 9, 2021
Sample Application (F31): Putnam
Last Reviewed: January 25, 2023
Immunology Interest Group (IIG) Newsletter September
Last Reviewed: October 6, 2022
DAIDS Memo Regarding the Revised Common Rule and Implementation
Last Reviewed: June 10, 2020
NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Radiological and Nuclear Threats
Last Reviewed: December 5, 2019
Last Reviewed: September 29, 2023
Last Reviewed: February 5, 2024
Last Reviewed: January 8, 2025